These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 10792381)
1. Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Furukawa Y; Bangham CR; Taylor GP; Weber JN; Osame M Clin Exp Immunol; 2000 May; 120(2):307-16. PubMed ID: 10792381 [TBL] [Abstract][Full Text] [Related]
2. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259 [TBL] [Abstract][Full Text] [Related]
3. Tax secretion from peripheral blood mononuclear cells and Tax detection in plasma of patients with human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis and asymptomatic carriers. Medina F; Quintremil S; Alberti C; Godoy F; Pando ME; Bustamante A; Barriga A; Cartier L; Puente J; Tanaka Y; Valenzuela MA; Ramírez E J Med Virol; 2016 Mar; 88(3):521-31. PubMed ID: 26241614 [TBL] [Abstract][Full Text] [Related]
4. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development. Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232 [TBL] [Abstract][Full Text] [Related]
6. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders. Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872 [TBL] [Abstract][Full Text] [Related]
7. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load. Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926 [TBL] [Abstract][Full Text] [Related]
8. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load. Kubota R; Nagai M; Kawanishi T; Osame M; Jacobson S AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1705-9. PubMed ID: 11080814 [TBL] [Abstract][Full Text] [Related]
9. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers. Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801 [TBL] [Abstract][Full Text] [Related]
10. Expression of TSLC1 in patients with HAM/TSP. Takenouchi N; Tanaka M; Sato T; Yao J; Fujisawa JI; Izumo S; Kubota R; Matsuura E J Neurovirol; 2020 Jun; 26(3):404-414. PubMed ID: 32285300 [TBL] [Abstract][Full Text] [Related]
11. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Burbelo PD; Meoli E; Leahy HP; Graham J; Yao K; Oh U; Janik JE; Mahieux R; Kashanchi F; Iadarola MJ; Jacobson S Retrovirology; 2008 Oct; 5():96. PubMed ID: 18937847 [TBL] [Abstract][Full Text] [Related]
12. T CD4+ cells count among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): high prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM). Casseb J; Posada-Vergara MP; Montanheiro P; Fukumori LM; Olah I; Smid J; Duarte AJ; Penalva de Oliveira AC Rev Inst Med Trop Sao Paulo; 2007; 49(4):231-3. PubMed ID: 17823752 [TBL] [Abstract][Full Text] [Related]
13. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients. Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234 [TBL] [Abstract][Full Text] [Related]
14. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy. Nakamura T Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of T Regulatory Lymphocytes Transcription Factors in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients. Ghezeldasht SA; Sadeghian H; Azarpazhooh MR; Shamsian SAA; Rafatpanah H; Mahmoodi M; Rezaee SA Appl Biochem Biotechnol; 2017 Aug; 182(4):1403-1414. PubMed ID: 28101786 [TBL] [Abstract][Full Text] [Related]
16. Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis. Nozuma S; Matsuura E; Kodama D; Tashiro Y; Matsuzaki T; Kubota R; Izumo S; Takashima H Retrovirology; 2017 Apr; 14(1):26. PubMed ID: 28420387 [TBL] [Abstract][Full Text] [Related]